Should I Get an MRI If I Used Depo-Provera?
Current clinical guidelines do NOT recommend routine MRI screening for all Depo-Provera users who are feeling well. However, the December 2025 FDA label update instructs providers to "monitor patients on Depo-Provera CI for signs and symptoms of meningioma." This means your doctor should be asking about headaches, vision changes, and neurological symptoms at every visit.
When MRI Screening IS Recommended
Researchers recommend neurological monitoring (including imaging) for women who used Depo-Provera for more than 10 years, patients over 40 years of age with prolonged use, any woman experiencing new headaches, vision changes, seizures, or other neurological symptoms, and women with a family history of meningioma. If you fall into any of these categories, discuss MRI screening with your doctor.
The MRI Process
Contrast-enhanced MRI of the brain is the gold standard for meningioma detection. The scan takes 30–60 minutes and uses gadolinium contrast dye to highlight tumors. If a meningioma is found, additional imaging may include MRI spectroscopy, CT angiography, or PET scanning to characterize the tumor. The MRI result is also critical evidence for your legal claim.
Cost and Insurance Coverage
Brain MRI costs $1,000–$5,000 without insurance. Most insurance plans cover MRI when ordered by a physician for diagnostic purposes (i.e., you have symptoms). If your doctor orders an MRI based on Depo-Provera use history and you are experiencing symptoms, the test should be covered. Keep all billing records — imaging costs are recoverable in your lawsuit.
Scientific Evidence
Medroxyprogesterone Acetate and Meningioma: A Global Issue
Roland N, Froelich S, Weill A (2025). Frontiers in Global Womens Health
View on PubMed→Use of High-Dose Medroxyprogesterone Acetate and Risk of Intracranial Meningioma
Roland N, Neumann A, Hoisnard L, Gagne JJ, Froelich S, Weill A (2024). The BMJ
View on PubMed→The Association between Medroxyprogesterone Acetate Exposure and Meningioma
Griffin BR et al. (2024). Cancers
View on PubMed→Frequently Asked Questions
Related Pages
Depo-Provera Meningioma Brain Tumor
Meningioma — a tumor in the tissue surrounding the brain — is the primary injury in Depo-Provera lawsuits. Studies show long-term users face up to a 5.6x increased risk. The tumor can cause seizures, vision loss, and require major brain surgery.
Depo-Provera Brain Tumor Symptoms
Meningioma symptoms develop gradually and include persistent headaches, vision changes, seizures, and cognitive decline. If you used Depo-Provera and experience these symptoms, request brain imaging from your doctor.
Depo-Provera Long-Term Use Risks
Long-term Depo-Provera use carries multiple serious risks: meningioma brain tumors (up to 5.6x risk), significant bone density loss (black box warning), weight gain, depression, and delayed return to fertility. The FDA recommends limiting use to 2 years.
Depo-Provera Settlement Amounts
No Depo-Provera meningioma cases have settled or gone to trial yet. Projected settlements based on comparable pharmaceutical brain injury litigation suggest $75,000 to $1.5 million+ depending on injury severity.
Pfizer Depo-Provera Lawsuit
Pfizer inherited Depo-Provera when it acquired Pharmacia & Upjohn in 2002. Despite international warnings dating to 2015, Pfizer did not add a U.S. meningioma warning until December 2025. Plaintiffs allege a pattern of delayed safety action prioritizing revenue over patient safety.
Depo-Provera Alternatives After Diagnosis
If you are diagnosed with a meningioma, the FDA recommends discontinuing Depo-Provera immediately. Safer contraceptive alternatives exist that do not carry meningioma risk, including copper IUDs, barrier methods, and non-progestin options.
Depo-Provera Military Veterans
Military women were disproportionately prescribed Depo-Provera due to its convenience for deployment. If you received Depo-Provera during military service and were later diagnosed with a meningioma, you may be eligible for both civil lawsuit compensation and VA benefits.
Depo-Provera Brain Tumor Lawsuits Lawsuit
Depo-Provera (medroxyprogesterone acetate / MPA) is a contraceptive injection administered every three months. Over 2,000 lawsuits consolidated in MDL 3140 in the Northern District of Florida allege that Pfizer failed to warn about a significantly elevated risk of meningioma — a tumor in the tissue surrounding the brain and spinal cord. Women who received the shot for more than one year face up to a 5.6-fold increased risk, and the risk escalates with duration of use.
View full case overview